Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Surveillance of drug resistance molecular markers in Plasmodium vivax before and after introduction of dihydroartemisinin and piperaquine in Thailand: 2009-2019.

Parasitology research - 1 Dec 2023

Suphakhonchuwong Nutnicha, Rungsihirunrat Kanchana, Kuesap Jiraporn

Abstract excerpt

Resistance to antimalarial drugs is a serious issue around the world. Widespread Plasmodium vivax and P. falciparum coinfections are commonly found in Thailand. Dihydroartemisinin and piperaquine (DHA-PPQ) have been used as first-line treatments for P. falciparum since 2015, and chloroquine (CQ) and primaquine (PQ) have remained first-line drugs for P. vivax for more than 60 years. Coinfections may lead parasites...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimalarials
Share to Biomarkers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Coinfection

Share to Drug Resistance

Share to Malaria, Vivax

Share to Plasmodium vivax

Share to Protozoan Proteins

Share to Thailand

Source

Identifiers

PMID: 37725258
DOI: 10.1007/s00436-023-07977-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Surveillance of drug resistance molecular markers in Plasmodium vivax before and after introduction of dihydroartemisinin and piperaquine in Thailand: 2009-2019.PMID 37725258Read ↗

Drug resistance markers in Plasmodium vivax isolates from a Kanchanaburi province, Thailand between January to May 2023.Semantic proximity Read ↗

Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016.Semantic proximity Read ↗

Prevalence and dynamics of antimalarial drug resistance mutations among the Plasmodium falciparum isolates in TAK Province, Thailand, during the period of 1998-2001.Semantic proximity Read ↗

Plasmodium vivax drug resistance markers: Genetic polymorphisms and mutation patterns in isolates from Malaysia.Semantic proximity Read ↗

The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 2014.Semantic proximity Read ↗

Molecular Surveillance of Plasmodium vivax and Plasmodium falciparum Drug Resistance Genes in the Republic of Korea: 2022-2025.Semantic proximity Read ↗

Plasmodium Falciparum Phenotypic and Genotypic Resistance Profile During the Emergence of Piperaquine Resistance From Royal Thai Army and Civilian patients in Northeastern ThailandSemantic proximity Read ↗

Surveillance of molecular markers of antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Federally Administered Tribal Area (FATA), Pakistan.Semantic proximity Read ↗

Polymorphisms of Potential Drug Resistant Molecular Markers in Plasmodium Vivax From China–Myanmar Border During 2008 to 2017Semantic proximity Read ↗

Phenotypic and genotypic characterization of Thai isolates of Plasmodium falciparum after an artemisinin resistance containment project.Semantic proximity Read ↗

Ten-Year Molecular Surveillance of Drug-Resistant Plasmodium spp. Isolated From the China-Myanmar Border.Semantic proximity Read ↗

Molecular surveillance of Plasmodium falciparum drug-resistance markers in Vietnam using multiplex amplicon sequencing (2000-2016).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.